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Self-renewal is a hallmark of stem cells and cancer,
but existence of a shared stemness program remains
controversial. Here, we construct a gene module
map to systematically relate transcriptional pro-
grams in embryonic stem cells (ESCs), adult tissue
stem cells, and human cancers. This map reveals
two predominant gene modules that distinguish
ESCs and adult tissue stem cells. The ESC-like tran-
scriptional program is activated in diverse human
epithelial cancers and strongly predicts metastasis
and death. c-Myc, but not other oncogenes, is suffi-
cient to reactivate the ESC-like program in normal
and cancer cells. In primary human keratinocytes
transformed by Ras and IkBa, c-Myc increases the
fraction of tumor-initiating cells by 150-fold, enabling
tumor formation and serial propagation with as few
as 500 cells. c-Myc-enhanced tumor initiation is
cell-autonomous and independent of genomic insta-
bility. Thus, activation of an ESC-like transcriptional
program in differentiated adult cells may induce
pathologic self-renewal characteristic of cancer
stem cells.
INTRODUCTION
The stem cell model of tissue organization posits that a small
number of progenitor cells maintains the self-renewal and orga-
nization of the tissue (reviewed by Beachy et al., 2004; Clarke
and Fuller, 2006). The unique ability of ESCs and adult tissue
stem cells to self-renew and give rise to multiple cell lineages
has formed the basic definitions of ‘‘stemness.’’ Accumulating
evidence suggests that cancers may have equivalent cancer
stem cells, defined as the small fraction of cells that can initiate
and perpetuate tumor growth and heterogeneity in serial trans-
plantation experiments (Al-Hajj et al., 2003; Bonnet and Dick,
1997). If cancers are truly maintained by a small population of
cancer stem cells, then the ability to identify, target, and elimi-
nate cancer stem cells would be critical for cancer diagnosis
and therapy. It has been theorized that a critical event in cancer
initiation may be the inappropriate activation of the self-renewal
machinery that is normally restricted to stem cells. However, itremains unclear whether activation of a normal stem cell pro-
gram is a pervasive feature or required element in common
human epithelial cancers.
Given the unique roles of normal stem cells in tissue mainte-
nance, recent evidence has suggested a surprising plasticity
of stem cell fates. Several types of adult tissue stem cells can
be apparently reprogrammed into cell types of other lineages
(Slack, 2007). In addition, introduction of four genes, c-Myc,
Oct4, Sox2, and Klf4, into mouse or human fibroblasts was
sufficient to reprogram them to confer pluripotency indistin-
guishable from authentic ESCs (Takahashi and Yamanaka,
2006; reviewed by Jaenisch and Young, 2008). These findings
raise the possibility that other types of stem cells, including can-
cer stem cells, may be experimentally created by the appropriate
combination of genes.
Several studies have attempted to define a core transcriptional
program of ‘‘stemness,’’ but the results have been controversial
(Fortunel et al., 2003; Ivanova et al., 2002; Ramalho-Santos
et al., 2002). Fortunel et al. compared the shared microarray ex-
pression profiles of ESCs, neural stem cells (NSCs), and hemato-
poietic stem cells (HSCs) across three independent studies, and
they only found a single gene shared among the three studies.
The inability to define a consensus stemness signature in a
gene-by-gene analysis may suggest that different types of stem
cells utilize distinct mechanisms to achieve self-renewal and plu-
ripotency. Alternatively, the failure to identify a robust signature
may be due to technical variations in stem cell isolation, degrees
of cell purity,microarrayplatforms, or statistical analysismethods.
Because intersection of gene-level analyses are more prone to
noise and are inherently limited by the technically worse data set
under consideration (Bild and Febbo, 2005; Segal et al., 2004;
Subramanian et al., 2005), we hypothesized that a higher-order,
systems-level analysis may improve the organization and classifi-
cation of stem cell transcriptional programs. Here, we use
a method termed genemodule map (Segal et al., 2004) to identify
shared expression programs of ESCs and adult tissue stem cells,
focusing on groups of genes, termedmodules, that are supported
by the consensus of multiple independent observations. We find
that adult tissue stem cells can be separated into two large
groups, one of which shares a core transcriptional program with
ESCs. Further, the ESC-like transcriptional program is frequently
activated in aggressive human epithelial cancers. c-Myc is
uniquely able to activate the ESC-like transcriptional program in
adult epithelial cells, which in the appropriate genetic context
confers cardinal properties of human cancer stem cells in vivo.Cell Stem Cell 2, 333–344, April 2008 ª2008 Elsevier Inc. 333
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Gene Module Map Relating Embryonic
and Adult Tissue Stem Cells
To systematically relate geneexpressionprogramsamongESCs,
adult stem cells, disease states, and key pathways that regulate
suchprograms,wecreatedamodulemapof stemcell genes (Fig-
ure 1A). We curated a compendium of mouse stem cell data, in-
cluding 102 genome-wide expression profiles of mouse ESCs,
NSCs,HSCs, retinal stemcells, neural crest stemcells, hair bulge
stem cells, mammary stem cells, and various differentiated cells
(Table S1 available online). We also compiled over 3,000 gene
sets, including signature genes that are differentially expressed
between mouse stem cells and their differentiated counterparts,
genes that are occupied by key stem cell transcription factors as
defined by genome-scale chromatin immunoprecipitation (ChIP-
chip or ChIP-PET), genes that are functionally regulated by key
stem cell factors as defined by RNA interference, and genes
that encode proteins with shared functions, such as those in
Gene Ontology and KEGG pathways (Table S2). Gene module
map enabled unbiased discovery of genes that are coordinately,
but perhaps subtly, regulated in one or more types of stem cells
as supported by multiple functional criteria and independent,
reproducible observation (see Supplemental Data).
Figure 1. Gene Module Analysis of Stem
Cells
(A) Flow chart of the steps in our gene module
analysis of stem cells.
(B) Mouse stem cell gene module map: a matrix of
gene sets (rows) versus expression arrays (col-
umns), where a red (or green) entry indicates that
the individual genes within the gene set are signif-
icantly induced (or repressed) in the expression
array more than expected by chance (FDR <
0.05, p < 0.01). The intensity of each entry corre-
sponds to the average fold change of all of the
genes within the gene set in the array. The arrays
are labeled as differentiated cells or the type of
stem cell. A subset of significant gene sets is
shown; redundant gene sets were removed for
clarity. Gene sets defined by gene ontology terms
are listed in black, published gene sets defined by
expression arrays of stem cells and differentiated
cells are listed in purple, gene set defined by
RNA interference experiments is listed in orange,
and gene set defined by genome-wide chromatin
immunoprecipitation experiments is listed in
blue. Note the clustering of two groups of stem
cells, labeled ‘‘ESC-like’’ and ‘‘adult tissue stem.’’
The module map of mouse stem cell
genes revealed the existence of at least
two distinct classes of adult tissue stem
cells (Figure 1B).We found that themouse
ESCs from four independent studies,
NSCs from three independent studies, fe-
tal liver HSCs, and retinal stem cells are
clustered together by the coordinate acti-
vation of a similar collection of gene sets
(collectively termed ‘‘ESC-like’’), demon-
strating that ESCs and a subset of adult tissue stem cells share
a robust transcriptional program. Interestingly, the ESC-like
signature was not composed of any downregulated gene sets,
suggesting that the repressed genes are not shared but instead
confer specificity among different types of stem cells. The ESC-
like gene sets included several stemcell signaturespreviously de-
fined inESCsandNSCs,aswell as selectgenesoccupiedbyOct4
and Nanog in ESCs by ChIP-PET and genes downregulated by
RNAi ofOct4,Nanog, orSox2 in ESCs. Gene signatures identified
by one study were significantly recapitulated in independent
studies by other groups, demonstrating the strength of genemod-
ule map in identifying shared expression patterns. The member
genes that hit in each of the gene sets are grouped together to
form the mouse ESC-like module (FDR < 0.05, p < 0.001; Table
S3). TheESC-likemodulecontainsmany transcriptional regulators,
in particular, several associated with pluripotency, including Sox2,
c-Myc, Dnmt1, Cbx3, Hdac1, and Yy1.Oct4 and Nanog are not in
the ESC-like module because they are specifically expressed in
ESCs. This result implies that a portion of the transcriptional
programmediated by these key ESC regulators,Oct4 andNanog,
can be regulated in other stem cells by alternate mechanisms.
In contrast, the majority of adult tissue stem cells, including
bone marrow HSCs, neural crest stem cells, hair bulge stem
cells, andmammary stem cells, clustered together by coordinate334 Cell Stem Cell 2, 333–344, April 2008 ª2008 Elsevier Inc.
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‘‘adult tissue stem’’) (Figure 1B). Bone marrow HSCs and hair
bulge stem cells from three and two independent studies,
respectively, each clustered together, demonstrating that the
gene module map approach accurately clusters the stem cell
transcriptional patterns. For instance, genes induced in hair
bulge stem cells as defined by two studies were each crossvali-
dated by activation in each other’s arrays and, furthermore, were
induced in bone marrow HSCs, mammary stem cells, and neural
crest stem cells relative to their differentiated counterparts. Inter-
estingly, NSCs profiled by three independent studies clustered
with ESCs, whereas the NSCs from a fourth study clustered
with the adult tissue stem cells; the reason for this discrepancy
is at present unclear. The member genes that hit in each of these
gene sets are grouped together to form the mouse adult tissue
stem gene module (FDR < 0.05, p < 0.001, Table S4). Notably,
the adult tissue stem module is populated by many transcrip-
tional regulators of differentiation, such as Hox genes, GATA
and forkhead family transcription factors, MLL family of histone
methyltransferases, and lineage-specific regulators like Rest.
Thus, the gene module map demonstrated two distinct classes
of stem cells, which we term ‘‘ESC-like’’ and ‘‘adult tissue stem.’’
In order to validate the stem cell gene modules defined in
mouse and identify the functional subset conserved in evolution,
we applied our gene module map analysis to a compendium of
human stem cell transcriptional profiles (Figure S1A). Similar to
themouse stemcellmodulemap,we first curated a compendium
of human stem cell data, including genome-wide expression
profiles of human ESCs, embryonal carcinoma cells, and various
differentiated cells (Table S1). We also compiled over 3,000 gene
sets, including signature genes that are differentially expressed
between human ESCs and their differentiated counterparts,
genes that are occupied by key stem cell transcription factors
as defined by genome-scale chromatin immunoprecipitation
experiments, and genes that encode proteins with shared func-
tions, such as those in Gene Ontology and KEGG pathways
(Table S2). The module map of human stem cell genes revealed
a robust human ESC-like gene module that is induced in two in-
dependent studies of human ESCs and embryonal carcinomas
(member genes listed in Table S5, FDR < 0.05, p < 0.0001). Im-
portantly, the human ESC-like module overlapped significantly
with the mouse ESC-like module (p < 1083, hypergeometric
distribution; Figure S1B), but not with the mouse adult tissue
stemmodule. We defined the 335 genes shared between mouse
and human as the core ESC-like gene module (Table S6).
An important caveat is that many stem cells were grown in
culture, and one of the most consistent and expected responses
of stem cells in culture is proliferation. Therefore, some of the
concordance in expression programs in stem cells, in particular
the ESCmodule, may be due to proliferation genes.We therefore
determined the contribution of genes directly related to prolifer-
ation as well as exposure to serum in culture (Chang et al., 2004;
Whitfield et al., 2002). A minority (31 and 5 percent) of the genes
in the core ESC-like module and adult tissue stem module, re-
spectively, have been previously shown to have periodic expres-
sion during the cell cycle or to be induced in response to serum.
Notably, neither stem cell module contained any of the genes
transcriptionally induced in the S and G2/M phases of the cell
cycle (Whitfield et al., 2002). Moreover, removal of the genesets associated with proliferation did not impact the clustering
of the ESC-like stem cell arrays or the conservation between
mouse and human ESC-like modules, demonstrating that the
ESC-like module is not simply a signature of proliferation.
Widespread Activation of the ESC Module
in Human Cancers and Impact on Cancer Prognosis
Previous studies have demonstrated that cell-type specific tran-
scripts from minority cell populations can be detected in tumor
samples (Perou et al., 2000), suggesting that a specific cancer
stem cell signature can be detected in expression profiles of
bulk tumors (Liu et al., 2007). To investigate whether a stem
cell expression signature is activated in human cancer, we ex-
amined the expression of genes comprising the core stem cell
signatures in a ‘‘human cancer compendium’’ of publicly avail-
able expression profiles of a variety of human cancers and their
corresponding normal tissues (Segal et al., 2004). The ESC-like
gene module is significantly activated in various human cancers
relative to corresponding normal tissue and repressed in various
normal tissues relative to cancer (Figures 2A and 2B). In contrast,
the adult tissue stem gene module has an opposite pattern: ac-
tivated in various normal tissues relative to cancer and repressed
in various human cancers relative to normal tissue. Thus, these
results suggest that diverse human cancers exhibit an ESC-like
expression pattern.
To investigate whether the varying degrees of ESC-like mod-
ule activation have clinical implications in human cancers, we
examined the expression of the ESC-like genes in a consecutive
series of 295 primary human stage I and II breast cancers (van de
Vijver et al., 2002). The expression profiles were biphasic, allow-
ing separation of these tumors into two classes: ESC-activated
and ESC-repressed (Figure 2C). The primary breast cancers
with the ESC-activated signature were significantly associated
with poorer tumor differentiation (p < 1016; data not shown),
consistent with cancers expressing a stem cell-like phenotype.
In addition, these tumors with activated ESC signature were
more likely to progress to metastasis and death (p < 104 and
p < 106, respectively; Figure 2C). Thus, the ESC-like signature
is a powerful predictor of prognosis in human breast cancer.
Multivariate analysis with patient age, tumor diameter, tumor
grade, estrogen receptor status, lymph node status, vascular
invasion status, mastectomy versus breast conserving therapy,
use or nonuse of chemotherapy, use or nonuse of hormonal
treatment, St. Gallen criteria, and National Institutes of Health
consensus criteria confirmed that the ESC-like signature is an
independent prognostic factor of metastasis and death (hazard
ratio = 1.7, p < 0.02 and hazard ratio = 2.2, p < 0.001, respec-
tively). We also examined the expression of the ESC-like genes
in 71 patients with stage I and II lung adenocarcinomas (Bhatta-
charjee et al., 2001). The expression profiles were biphasic, and
the tumors with the ESC-activated signature were associated
with significantly higher risk of death compared to tumors with
the ESC-repressed signature (p < 0.03; Figure 2D). These data
demonstrate that the degree of ESCmodule activation is associ-
ated with poor differentiation and increased risk of metastasis
and mortality in multiple tumor types.
All of the human cancer expression array data examined
above were from bulk tumor tissue. However, multiple studies
have demonstrated that only a small fraction of the cells in aCell Stem Cell 2, 333–344, April 2008 ª2008 Elsevier Inc. 335
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(A) Cancer gene module map: a matrix of stem cell gene modules (columns) and array clinical annotations (rows), where a red (or green) entry indicates that the
arrays in which the corresponding module was significantly induced (or repressed) contained more arrays with a given annotation than would be expected by336 Cell Stem Cell 2, 333–344, April 2008 ª2008 Elsevier Inc.
Cell Stem Cell
Module Map Guides Creation of Cancer Stem Cellscancer have the unique ability to initiate and perpetuate tumor
growth and heterogeneity based on transplantation in immuno-
deficient mice (Al-Hajj et al., 2003; Bonnet and Dick, 1997). In or-
der to determine whether the ESC-like gene expression program
may be expressed in the tumorigenic cancer stem cell subpop-
ulation, we first examined the expression of the ESC-like gene
module in theCD44+CD24/low subpopulation of breast cancer
cells that are uniquely enriched for cancer stem cells (Liu et al.,
2007). Liu et al. previously defined a gene expression signature
based on the profiles of these enriched tumorigenic breast
cancer cell populations relative to normal breast tissues. This
184-gene signature has an overlap of only four genes with our
335-gene core ESC-like gene module. However, despite the
fact that the flow-sorted populations are only partially enriched
for cancer stem cells, of the CD44+CD24/low populations in
six independent breast cancers, two had significantly upregu-
lated the ESC-like gene module relative to normal breast tissue
(Figure 2E), suggesting that the ESC-like signature may be
activated in cancer stem cell populations. We also examined
the coregulation of these two signatures in an independent set
of primary human breast cancers (van de Vijver et al., 2002).
Strikingly, expression of the ESC-like signature is significantly
correlated with expression of the cancer stem cell-enriched
CD44+CD24/low subpopulation signature in these primary hu-
man breast cancers (R = 0.52, p < 1021; Figure 2F). Thus, these
results suggest that the ESC-like signature may be activated in
the tumorigenic fraction of cancer cells.
c-Myc Activates the ESCModule in Adult Epithelial Cells
Togain further insight into themechanisms bywhich the ESC-like
modulemaybedirectly regulated,weperformeda computational
screen of cis-regulatory motifs that are enriched among the
ESC-like module genes. We analyzed all 903 single, double, and
three-way combinations of cis-regulatorymotifs in TRANSFACor
identified by evolutionary conservation (Sinha et al., 2008). The
top motifs or motif combinations significantly enriched among
the ESC-like module genes are listed in Table S7. Notably, the
cis-regulatory motifs that had the most occurrences at the top
of the enriched list included that of c-Myc (binding motifs of
MYC, MAX, and the MYC/MAX dimer) and HNF1 (binding motifs
of HNF1, HNF1:SP1 pair, and HNF1:KROX pair). In combination
withpreviousdata showing that c-Myc is necessary andsufficient
to maintain mouse ESC self-renewal (Cartwright et al., 2005) and
is one of four genes sufficient to reprogram mouse and human
fibroblasts to confer pluripotency indistinguishable from authen-
tic ESCs (Takahashi and Yamanaka, 2006; reviewed by Jaenisch
and Young, 2008), this unbiased cis-regulatory motif analysis
suggested that c-Myc may be a dominant regulator of the
ESC-like program.Based on this result, we next examined gene expression pro-
files of c-Myc aswell as four additional oncogenic pathways (Bild
et al., 2006). Intriguingly, we found that c-Myc, but not other on-
cogenic proteins such as Src, b-catenin, E2F3, and Ras, can co-
ordinately induce expression of the ESC-like module in primary
human mammary epithelial cells (Figures 3A and 3B). c-Myc
also substantially inactivated the adult tissue stem gene module
(Figure 3C). This result suggested that c-Mycmay act as a switch
between these apparently mutually exclusive transcriptional
programs. We similarly observed induction of the ESC-like mod-
ule by c-Myc in primary human fibroblasts and a nontransformed
breast epithelial cell line (Figures S2A and S2B; Adler et al., 2006;
Coller et al., 2000). In addition, 88 of the 335 (26%) ESC-like
module genes have been previously identified as c-Myc targets
(http://www.myc-cancer-gene.org/). To extend this result in vivo,
we examined in detail the transcriptional response following
induction of c-Myc in the epidermis by topical application of
tamoxifen to K14-Myc-ER transgenic mice (Frye et al., 2003)
and in pancreatic beta cells by systemic administration of
tamoxifen in pIns-Myc-ER transgenic mice (Lawlor et al., 2006).
Consistent with results in cultured cells, Myc-ER activation co-
ordinately induced the ESC-like module (Figures 3D and 3E;
Figure S2C). In addition, Myc-ER activation silenced the adult
tissue stem module (Figure 3F). Previous studies had docu-
mented that c-Myc induction in epidermis blocks hair follicular
stem cell function (Arnold and Watt, 2001; Waikel et al., 2001).
Our finding of the silencing of the adult tissue stemmodule (char-
acteristic of hair bulge stem cells), therefore, anticipates the pre-
viously observed biological phenotype and validates the gene
module approach. In addition, these findings suggest that an un-
anticipated consequence of c-Myc induction is the reactivation
of the ESC-like module in adult epithelia.
c-Myc Activates the ESC Module in Human Cancer
and Induces Epithelial Tumor-Initiating Cells
To determine the consequences of c-Myc-induced ESC module
activation in human cancers, we turned to a genetically defined
in vivo model of human epithelial cancer. Primary human kerati-
nocytes transduced with oncogenic Ras and a stabilized mutant
of the NF-kB repressor IkBa, which are then grafted onto immu-
nodeficient scid mice, produce well-differentiated squamous
cell carcinomas (SCCs) that are phenotypically indistinguishable
from authentic human lesions (Dajee et al., 2003). We retrovirally
transduced primary human keratinocytes with oncogenic Ras
and IkBa, plus either GFP, E2F3, or c-Myc. E2F3 serves as a
control oncogene because it promotes proliferation but does
not activate the ESC-like module (Figures 3A and 3B). Injection
of 5 3 105 transduced keratinocytes of each genetic combina-
tion led to gross tumor formation with 100% efficiency, butchance (FDR < 0.05, p < 0.01). The intensity of the entries corresponds to the significance, i.e., log10 (p value). A subset of significant annotations is shown;
redundant annotations were removed for clarity.
(B–D) Expression patterns of ESC-like genes in primary human cancers and corresponding normal tissues are organized by hierarchical clustering. Note the
coordinate regulation of the genes in the normal and cancer tissues. The dendrogram at the top of each data represent the similarities among the samples in
their expression of ESC-like genes. Tumors are indicated by black branches, and normal tissues are indicated by green branches. Kaplan-Meier survival curves
of tumors stratified into two classes based on expression of the ESC-like module are shown for data in (C) and (D).
(E) Average log2 expression value of all the genes in the ESC-like module in previously published expression arrays of normal breast and FACS-sorted
CD44+CD24/low tumorigenic breast cancer cells (Liu et al., 2007). A line indicating mean expression value among all samples is shown for each.
(F) Correlation of Pearson value to CD44+CD24/low tumorigenic breast cancer cell signature with average log2 expression value of ESC-like module in the
primary human breast cancers shown in (C).Cell Stem Cell 2, 333–344, April 2008 ª2008 Elsevier Inc. 337
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Epithelial Cells
(A) Expression of ESC-like module genes (exclud-
ing the proliferation genes) in previously published
expression arrays of primary humanmammary ep-
ithelial cells transduced with indicated oncogenes
relative to those cells transduced with GFP (Bild
et al., 2006). Each row represents an individual
gene within the ESC-like module, and each col-
umn is an expression array. The level of expression
of each gene in each sample relative to the mean
level of expression of that gene in the cells trans-
duced with GFP is represented using a red-green
color scale.
(B) Average log2 expression values of all of the
genes in the ESC-like gene module are expressed
as mean ± SEM.
(C) Average log2 expression values of all of the
genes in the adult tissue stem genemodule are ex-
pressed as mean ± SEM.
(D) Expression of ESC-like module genes (exclud-
ing the proliferation genes) in previous published
expression arrays of c-Myc induction in the epi-
dermis of K14-Myc-ER transgenic mice 1 and
4 days after topical application of tamoxifen
(Frye et al., 2003).
(E) Average log2 expression values of all of the
genes in the ESC-like gene module are expressed
as mean ± SEM.
(F) Average log2 expression values of all of the
genes in the adult tissue stem gene module are
expressed as mean ± SEM.with marked differences in gene expression and histology. First,
microarray analysis showed that c-Myc, but not GFP or E2F3, led
to the strong and coordinate activation of the ESC-like module in
the generated SCCs, indicating that c-Myc expression is suffi-
cient to activate the ESC-like module in human epithelial tumors
in vivo (Figure 4A). For instance, c-Myc induced SOX2, a key
transcriptional regulator in embryonic stem cells. In addition to
activation of specific genes, ESCs are also characterized by
silencing lineage-specific developmental regulators, frequently
marked by ‘‘bivalent’’ chromatin domains bearing both histone
H3 K4 and K27 methylation. Of the 87 genes previously de-
scribed within the ‘‘bivalent’’ chromatin domains (Bernstein
et al., 2006), 49 were present on our expression arrays; 26 of
these 49 genes significantly changed in expression, and all but
two were repressed in the c-Myc-Ras-IkBa tumors relative to
the GFP-Ras-IkBa tumors (Figure 4B). Thus, c-Myc expression
led to transcriptional silencing of canonical ESC bivalent genes,
such as HOX genes. Strikingly, the c-Myc-Ras-IkBa tumors also
specifically activated a gene expression signature of the cancer
stem cell as previously defined by the CD44+CD24/low popu-
lation (Figure 4C; Liu et al., 2007), suggesting an increased can-
cer stem cell population in the c-Myc-Ras-IkBa tumors. Thus,
these three independent gene signatures—the ESC-like module,
ESC bivalent genes, and a signature of CD44+CD24/low cells
enriched for cancer stem cells—suggest a reprogramming of
the cancer cells to a state resembling ESCs and potentially
cancer stem cells.338 Cell Stem Cell 2, 333–344, April 2008 ª2008 Elsevier Inc.c-Myc-transduced tumors were also strikingly different in his-
tological appearance (Figure 4D). Despite having a high fre-
quency ofmitotic figures, the E2F3-Ras-IkBa tumors, like control
GFP-Ras-IkBa tumors, were well-differentiated squamous cell
carcinomas, characterized by mitotically active cells adhering
to basement membranes that stratify to give rise to eosinophilic
cells with decreased nuclear to cytoplasmic ratios and keratin
whorls (Figure 4D; Figure S3A; data not shown). In contrast,
the c-Myc-Ras-IkBa tumors formed poorly differentiated tu-
mors, composed of mostly basophilic cells with nuclear pleo-
morphism and atypia with high nuclear-to-cytoplasmic ratios.
Moreover, c-Myc-transduced tumors showed absence of strat-
ification and tissue polarity. Grading of the tumors on histologic
sections by a dermatopathologist unaware of the genotypes
confirmed the poor differentiation of the tumors that overex-
pressed c-Myc (Figure 4E). Immunofluorescence staining dem-
onstrated that the c-Myc-Ras-IkBa tumors lost expression of
differentiated epidermal markers, including transglutaminase 1
and keratin 10 (Figure 4F), demonstrating that c-Myc is sufficient
to inhibit differentiation of the keratinocyte-derived carcinoma.
The c-Myc-Ras-IkBa tumors retained keratins 5 and 14, which
are expressed by the basal cell compartment of the skin epider-
mis that contains the epidermal stem cells, demonstrating that
they still express the undifferentiatedmarkers of the keratinocyte
lineage (Figure 4F; data not shown). In addition, the c-Myc-Ras-
IkBa tumors activated expression of keratin 8, which is
a marker of simple epithelia, suggesting that c-Myc induces
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seen with tumors derived from transduced keratinocytes that
were placed on devitalized dermis and grafted onto scid mice
(data not shown).
The ability of c-Myc to induce an ESC-like transcriptional
program and tumor dedifferentiation raised the possibility that
c-Mycmay promote the formation of epithelial cancer stem cells.
Therefore, we performed a limiting dilution analysis to determine
whether c-Mycwas sufficient to increase the fraction of epithelial
tumor-initiating cells (Table 1). Transduced keratinocytes were
diluted in a 10-fold series from 53 105 to 50 cells prior to subcu-
taneous injection into scid mice. With 5 3 105 injected cells, co-
expression of c-Myc or E2F3 produced more rapidly growing
tumors than cells transduced with GFP-Ras-IkBa, confirming
the expected role of c-Myc and E2F3 in tumor mass proliferation
(Figure 5A). With 5 3 104 injected cells, both E2F3- and GFP-
transduced tumors grew much more slowly and formed tumors
at substantially lower efficiency compared to c-Myc-transduced
tumors (Figure 5B). Strikingly, all 16 injections of 53 103 c-Myc-
Ras-IkBa cells formed tumors, whereas none of the injections of
5 3 103 GFP-Ras-IkBa or E2F3-Ras-IkBa cells formed a tumor
(Figure 5C). In fact, as few as 500 c-Myc-Ras-IkBa cells were
sufficient to form a tumor in 3 of 17 injections (Figure 5D). All
Figure 4. c-Myc Induces ESC-like State in
Cancer
Subcutaneous scid mouse tumors derived from
transduced primary human keratinocytes ex-
pressing the indicated proteins.
(A–C) Each row represents an individual gene, and
each column is an expression array of a subcuta-
neous tumor. The level of expression of each
gene in each sample was normalized relative to
its average expression in all the samples and is
represented using a red-green color scale.
(A) RNA expression of genes in the ESC-like
module.
(B) RNA expression of genes with bivalent
chromatin domains that are repressed in ESCs
(Bernstein et al., 2006).
(C) RNA expression of genes in a signature of
CD44+CD24/low cancer cell subpopulation en-
riched for cancer stem cells (Liu et al., 2007). The
CD44+CD24/low signature is composed of
genes that are induced and repressed, which is
shown on the bar to the right (red is induced; green
is repressed).
(D) Histology of subcutaneous tumors.
(E) Grades of subcutaneous tumors.
(F) Subcutaneous tumor tissue: protein expression
of keratinocyte differentiation markers keratin 5
(K5), keratin 10 (K10), transglutaminase 1 (Tgase),
and keratin 8 (K8), all in orange. Hoechst 33342
nuclear staining in blue.
of the c-Myc-Ras-IkBa tumors formed
were histologically identical to those
formed with 5 3 105 cells (Figure S3B).
Based on a Poisson distribution (Fazekas
de St, 1982), we estimate that c-Myc
increased the frequency of successful
tumor initiation events from 1/330,000 to
1/2,200 cells, a 150-fold increase in efficiency. We next per-
formed serial retransplantation experiments from three c-Myc-
Ras-IkBa tumors derived from initial injection of as few as 500
cells, as well as from two GFP-Ras-IkBa tumors. Tumors were
excised at 6 weeks after initial injection, digested into a single
cell suspension, and then reinjected into new recipient scid
mice. Neither of the two injections from the GFP-Ras-IkBa tu-
mors formed secondary tumors. In contrast, all three injections
from the c-Myc-Ras-IkBa tumors formed secondary tumors
with identical histology to the original tumor (Figure S3C) and
identical growth kinetics, providing further evidence for self-re-
newal capacity of experimentally created tumor-initiating cells.
Thus, c-Myc is sufficient to induce a dramatic increase in the
cancer stem cell population.
c-Myc-Mediated Tumor Initation Is Cell-Autonomous
and Not Linked with Genomic Instability
c-Mycmay increase the success of tumor initiation by increasing
the fraction or efficiency of tumor-initiating cells (the seed); alter-
natively, c-Myc may enhance the cancer stem cell niche by
altering the tumor microenvironment (the soil). To distinguish be-
tween these possibilities, we performed a cell-mixing experi-
ment. As shown above in the limiting dilution analysis, 5 3 104Cell Stem Cell 2, 333–344, April 2008 ª2008 Elsevier Inc. 339
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Module Map Guides Creation of Cancer Stem CellsGFP-Ras-IkBa cells forms a tumor at a substantially slower rate
and efficiency than 53 104 c-Myc-Ras-IkBa cells. Wemixed 53
104 c-Myc-Ras-IkBa cells and 53 104 GFP-Ras-IkBa cells, and
then we injected these cells subcutaneously into scid mice
(n = 3). The resulting tumors appeared histologically identical
to tumors injectedwith c-Myc-Ras-IkBa cells alone andwere de-
rived exclusively from c-Myc-transduced cells (Figure 6A). The
lack of promotion of GFP-marked, non-c-Myc transduced cells
suggests that the remarkable improvement in tumor initiation is
a cell-autonomous effect of c-Myc and, thus, is likely due to an
effect on inducing tumor-initiating cells.
In addition to its role in gene regulation, c-Myc expression can
also induce genomic instability in certain settings (Felsher and
Bishop, 1999). A possible alternative explanation of these results
is the accumulation of de novo mutations in c-Myc-transduced
cells, leading to the acquisition of tumor-initiation activity. To
evaluate this possibility, we performed array-based comparative
genomic hybridization of wild-type cells and tumors with all three
genotypes and found no evidence of significant genomic ampli-
fications or deletions in any of the tumors (Figure 6B). Thus, the
increase in tumor-initiating cells in the c-Myc-Ras-IkBa tumors is
not due to induction of genomic instability. While these results do
not exclude the possibility of additional functions of c-Myc that
may contribute to tumor initiation, they support the idea that
c-Myc-mediated activation of tumor initiation likely occurs in a
direct manner.
DISCUSSION
Module Map of Stem Cells as an Engine
of Biological Discovery
By assembling and relating the gene expression signatures of
ESC and diverse tissue stem cells, we have created a module
map where diverse sources of data can be integrated and higher
order relationships among the transcriptional programs of stem
cells populations may be revealed. Where gene-level analyses
failed to observe commonalities in gene expression between
stem cell signatures identified by different labs (Fortunel et al.,
2003), the module map was able to systematically organize
ESCs and various adult tissue stem cells profiled by at least
two or more laboratories with their expected biological neigh-
bors. Moreover, the map confirms that there is no single ‘‘stem-
ness’’ program shared across all stem cells. Instead, select tis-
sue stem cells, notably fetal liver HSCs, retinal stem cells, and
a subset of NSCs, share a core transcriptional program with
ESCs. The finding that NSCs and retinal stem cells are the only
normal adult stem cells examined to share the ESC module is
Table 1. Tumorigenicity Is Highly Enriched by c-Myc
No. of Cells per Injection
Genotype 5 3 105 5 3 104 5 3 103 5 3 102 5 3 101
GFP+Ras+IkB 3/3 1/7 0/10 0/10 0/10
E2F3+Ras+IkB 3/3 2/5 0/12 0/12 0/10
c-Myc+Ras+IkB 3/3 7/7 16/16 3/17 0/17
Number of tumors formed over number of subcutaneous injections
performed is shown.340 Cell Stem Cell 2, 333–344, April 2008 ª2008 Elsevier Inc.intriguing and may relate to the fact that neuralization is the
default, presumably ground-state, ectodermal fate during devel-
opment (Weinstein and Hemmati-Brivanlou, 1999). In contrast,
Figure 5. c-Myc Increases Fraction of Tumor-Initiating Cells
Left: growth kinetics of tumors formed after subcutaneous injection of trans-
duced primary human keratinocytes expressing the indicated proteins
(mean ± SEM). Right: representative pictures of subcutaneous tumors in
scid mice: c-Myc+Ras+IkB tumors on left flank and GFP+Ras+IkB tumors
on right flank. (A) 5 3 105 cells per subcutaneous injection. Picture is at day
18 postinjection. (B) 5 3 104 cells. The growth kinetics shown for GFP+
Ras+IkB is of the one tumor that formed. The growth kinetics shown for E2F3+
Ras+IkB is themean ± SEM of the two tumors that formed. Picture is at day 20.
(C) 5 3 103 cells. Picture is at day 28. (D) 5 3 102 cells. The growth kinetics
shown for Myc+Ras+IkB is the mean ± SEM of the three tumors that formed.
Picture is at day 45.
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crest, hair bulge, bone marrow HSCs, and mammary stem cells
share a distinct transcriptional program. The map also defined
the gene composition of the two stem cell modules, which opens
future investigation into the unique molecular networks of these
two distinct stem cell classes.
In addition to classifying different types of stem cells, the map
of gene modules also facilitated the connection of stem cell tran-
scriptional programs to human cancers and mechanistic investi-
gations of their control. We found that the ESC-like module was
induced in many aggressive human epithelial cancers; the ESC
module can be induced by c-Myc, creating highly tumorigenic
cells that can initiate cancer with as few as 500 cells. The map
can be used to establish improved standards for classifying
and defining stem cells, by using the expression signature mod-
ules as ‘‘fingerprints’’ rather than reliance on just a fewmolecular
markers. Further studies will be needed to determine the speci-
ficity of the ESC-like signature as a marker for cancer stem cells.
In addition, this map can be used to ask additional questions
about the role of stem cell expression programs in other disease
states as well as normal development.
Figure 6. c-Myc-Mediated Tumor Initation Is
Cell-Autonomous and Not Linked with Genomic
Instability
(A) Subcutaneous scid mouse tumors derived from injec-
tion of 5 3 104 transduced primary human keratinocytes
expressing GFP, Ras, and IkB (100% GFP+Ras+IkB);
5 3 104 cells expressing c-Myc, Ras, and IkB (100%
Myc+Ras+IkB); or 2.5 3 104 cells expressing GFP, Ras,
and IkB plus 2.5 3 104 cells expressing c-Myc, Ras, and
IkB (50% GFP+Ras+IkB, 50% Myc+Ras+IkB). Histology
and immunohistochemistry with antibody against GFP.
(B) Graphical displays of genome-wide DNA copy number
alteration of subcutaneous tumors using array-based
comparative genomic hybridization. Ratios are plotted
on a log2 scale according to chromosome position.
Experimental Induction of Epithelial
Tumor-Initiating Cells by Reactivation
of an ESC Transcriptional Program
Because purified fractions of putative cancer
stem cells can initiate tumor growth with a few
hundred cells while hundreds of thousands of
other cells from the bulk tumor cannot, cancer
stem cells are likely key cells of origin for cancer
establishment and metastasis. We show that
the reactivation of an ESC-like transcriptional
program in primary human keratinocytes, medi-
ated by c-Myc, is able to create cells that can
initiate epithelial tumor growth with comparable
efficiency as bona fide cancer stem cells, at
least as defined by current standards. The
ESC-like transcriptional program we defined is
clinically relevant because it is frequently acti-
vated in human epithelial cancers and predicts
cancer metastasis and death. Further, the
ESC-like gene module is enriched in tumor initi-
ating cells purified from authentic human can-
cers. Our findings suggest that inappropriate
activation of the ESC-like transcriptional program in adult epithe-
lial cells can induce epithelial tumor initiating cells. Because pre-
vious studies in leukemia stem cells have demonstrated reacti-
vation of HSC transcriptional programs (Krivtsov et al., 2006),
reactivation of tissue-specific, adult stem cell programs may
have been predicted to underlie cancer stem cells from different
epithelial cancers. However, ectopic activation of Oct4, an ESC-
specific transcription factor, in adult epithelia induces dysplasia
(Hochedlinger et al., 2005), suggesting that off-lineage activation
of an ESC-like transcriptional program can promote cancer. Our
results add to the latter idea and suggest that ESC-like module
activation is prevalent in common human epithelial cancers. A
relationship between increased tumor-initiating cell numbers
and metastatic potential is intriguing, but its mechanistic basis
will require further investigation.
The ability to experimentally create cells with many properties
of epithelial cancer stem cells has several potentially important
implications. Currently, purification of cancer stem cells from
human tumors is limited by patient heterogeneity and availability
of fresh and sizable tumor samples. Moreover, current markers
enrich for but do not allow complete purification of human cancerCell Stem Cell 2, 333–344, April 2008 ª2008 Elsevier Inc. 341
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epithelial cancer stemcells, offeringmany newpossibilities to im-
prove cancer diagnosis and treatment. For instance, the gene ex-
pression profiles of genetically induced tumor-initiating cells can
be used to identify cell surface or secreted proteins enriched in
this population, which may be used to guide the identification,
further purification, and blood-based detection of incipient can-
cer. Uniform sources of experimentally created tumor-initiating
cells may also be used for drug screening to identify compounds
that specifically target cancer stem cells. Further, a key goal in
cancer research is to identify the mechanism by which cancer
stem cells arise and self-renew. Experimentally created and
genetically defined tumor-initiating cells offer the possibility of
dissecting the temporal and functional dynamics of these
processes.
c-Myc as a Switch of Stem Cell
Transcriptional Programs
c-Myc represents one of likely several oncogenes that play a role
in normal stemcell biology andmayalsopromote the formationof
cancer stem cells. Our finding that c-Myc activates the ESC-like
program but downregulates the adult tissue stem program is
consistent with previous studies showing that sustained c-Myc
promotes self-renewal and blocks differentiation in ESCs and
cancer but, conversely, promotes differentiation with depletion
of stem cells in hair bulge and bone marrow (Arnold and Watt,
2001; Arvanitis and Felsher, 2006; Cartwright et al., 2005; Waikel
et al., 2001; Wilson et al., 2004). The recent finding of c-Myc as
oneof the four keygenes sufficient to reprogrammouseor human
fibroblasts into embryonic stemcells highlights the importance of
c-Myc as an enforcer of ESC fate. This unique functionmay relate
to c-Myc’s ability to globally reprogram chromatin (Knoepfler
et al., 2006; Wu et al., 2007). The concept of cancer stem cells
has recently been challenged by the observation of frequent
(>1/10) tumor-initiating cells in murine lymphoma (Kelly et al.,
2007); interestingly, the strongest effect came from the Em-Myc
model. Our data provide apotential explanation for these findings
and reinforce the unique role of c-Myc as an oncogene.
Our results suggest that the ESC-like program is not simply
a proliferation signature. The ESC-like program, derived from
a gene module map without gene sets associated with prolifera-
tion, was activated in diverse human cancers and predictive of
mortality and metastasis. Moreover, enforced cell-cycle entry
by E2F3 overexpression was able to activate a proliferation sig-
nature but unable to induce the ESC-like signature or enhance
tumor initiation, indicating that c-Myc’s role is more than simply
driving cell proliferation. However, we were not able to demon-
strate that the ESC-like signature provides independent prog-
nostic value over a proliferation signature; nor is it clear whether
the ESC-like signature is expressed in rare cancer stem cells or
the bulk tumor in human cancer samples. Thus, additional
studies will be needed to address these important issues.
EXPERIMENTAL PROCEDURES
Gene Module Map
Gene module map was implemented with the programGenomica (Segal et al.,
2004). We downloaded data available on GEO database or as attachments to
manuscripts on journal websites as well as those given directly from authors342 Cell Stem Cell 2, 333–344, April 2008 ª2008 Elsevier Inc.upon request (Table S1). We normalized the expression of each gene in every
data set separately. Genomica and the full gene module maps can be
downloaded and interactively queried at http://genie.weizmann.ac.il.
Data Analysis
All of the analyses of the ESC-like genemodule were performed both including
and excluding the proliferation genes within the module and showed consis-
tent results regardless of inclusion or exclusion of those genes. In all of the fig-
ures except for Figure 3, the ESC-like gene module including the proliferation
genes is shown. For clarity, in Figure 3, the results of the analyses are shown
using the ESC-like module excluding the proliferation genes because E2F3 in-
duces the proliferation genes (Figure S4), but not the remainder of the ESC-like
module.
Cell Culture and Gene Transfer
Coding regions of human c-Myc, E2F3, Ha-Ras G12V, and IkBaM, as well as
GFP, were subcloned into the LZRS retroviral vector. Virus was produced as
described previously (Robbins et al., 2001). Primary human keratinocytes
isolated from normal human skin were serially transduced at intervals of
12–24 hr. We verified that gene transfer efficiency was higher than 99% by
immunostaining.
Animal Studies
Eight-week-old scid mice were injected subcutaneously with cells resus-
pended in 100 ml PBS and 50 ml Matrigel. Tumor growth was followed for
10 weeks. For serial propagation assays, subcutaneous tumors were excised,
minced, and digested into a single cell suspension, prior to subcutaneous
injection into scid mice. All animal studies were conducted in compliance
with appropriate Stanford institutional review boards.
Microarrays
Total RNA from the subcutaneous tumors was purified, amplified, and then la-
beled by direct incorporation of Cy5. Universal human RNA reference from
pooled cell lines (Stratagene) was amplified and labeled by direct incorpora-
tion of Cy3. These fluorescent cDNA probes were hybridized to human
cDNA arrays containing over 41,000 elements, representing over 27,000
unique genes. Array data is publicly available at GEO GSE10423.
Tissue Analysis
For histological analysis, a portion of each subcutaneous tumor was fixed in
10% formalin (Sigma-Aldrich) and embedded in paraffin. Immunohistochemis-
try was performed on the formalin-fixed paraffin sections with antibody spe-
cific to GFP (Abcam). Another portion of each subcutaneous tumor was snap
frozen in OCT for immunofluorescence. Nuclei were stainedwith Hoeschst dye
33342. Primary antibodies used were specific to keratin 5 (Covance), keratin 8
(Abcam), keratin 10 (Neomarkers), keratin 14 (Covance), and transglutaminase
1 (Biomedical Tech).
Comparative Genomic Hybridization
Genomic DNA from the subcutaneous tumors was isolated, digested, and then
labeled by direct incorporation with Cy5. DNA isolated from the blood of a nor-
mal donor was used as reference, which was labeled with Cy3. Labeled tumor
and reference DNAs were competitively hybridized to human cDNA microar-
rays as previously described (Pollack et al., 1999).
SUPPLEMENTAL DATA
The Supplemental Data include Supplemental Experimental Procedures, four
figures, and eight tables and can be foundwith this article online at http://www.
cellstemcell.com/cgi/content/full/2/4/333/DC1/.
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